They're assuming growth stagnates - I don't think the analysts realise how big the market is and how much of the pie PNV is poised to take.
How much penetration have we achieved? Not just in the US, but world wide.
We are still in the accelerating growth phase in my opinion, and they see us decelerating quite rapidly later this year - when we haven't even begun selling into India for instance, when we don't even have the BARDA trial finished (which should lead to increased uptake due to reimbursement, not to mention potential for stockpiling, etc).
They're absolutely underestimating, which is good for those of us who understand the market a bit better.
IMO DYOR
PNV - Banter and General Comments, page-11455
-
- There are more pages in this discussion • 931 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.64 |
Change
-0.010(0.38%) |
Mkt cap ! $1.823B | |||
| Open | High | Low | Value | Volume |
| $2.62 | $2.64 | $2.58 | $2.297M | 877.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2375 | $2.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.64 | 3584 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| PNV (ASX) Chart |